What type of equity award led to the 58,832-share acquisition reported for KMTS?

The 58,832-share acquisition for KMTS resulted from performance-based RSUs (PSUs) . These PSUs were granted on July 17, 2025 and earned based on the issuer’s achievement of specified performance goals, with 100% of the PSUs vesting on July 15, 2026.

Kestra Medical Technologies (KMTS) CCO awarded 58,832 performance-based shares

Q: What insider transaction did KMTS report for Alfred J. Ford Jr.?

Alfred J. Ford Jr., Chief Commercial Officer, acquired 58,832 Common Shares of KMTS on July 15, 2026. The shares were earned from a performance-based RSU award granted July 17, 2025 that vested 100% based on specified performance goals.

Q: On what dates were the KMTS PSUs granted and when did they fully vest?

The performance-based RSUs for KMTS were granted on July 17, 2025 and vested 100% on July 15, 2026 . Vesting and share delivery were contingent on the issuer’s achievement of specified performance goals linked to that PSU award.

Q: Was the KMTS insider transaction by Alfred J. Ford Jr. under a Rule 10b5-1 plan?

The Form 4 for KMTS indicates the transaction was not marked as pursuant to a Rule 10b5-1 plan . The document-level 10b5-1 checkbox is unchecked, so the reported award vesting is not identified as occurring under a pre-arranged trading plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kestra Medical Technologies Chief Commercial Officer Alfred J. Ford Jr. acquired 58,832 Common Shares on July 15, 2026 at $0.00 per share. The shares were earned from performance-based RSUs granted July 17, 2025, which vested 100%, bringing his direct holdings to 133,471 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ford Alfred J Jr

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	58,832	$0.00	--

Holdings After Transaction: Common Shares — 133,471 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Shares acquired: 58,832 Common Shares Price per share: $0.0000 Holdings after transaction: 133,471 Common Shares +2 more

5 metrics

Shares acquired 58,832 Common Shares Common Shares earned from performance-based RSUs on July 15, 2026

Price per share $0.0000 Reported transaction price per Common Share for the award-related acquisition

Holdings after transaction 133,471 Common Shares Total direct Common Share holdings of Alfred J. Ford Jr. after PSU vesting

PSU grant date July 17, 2025 Grant date of performance-based RSUs that generated the earned shares

PSU vesting date July 15, 2026 Date on which 100% of the performance-based RSUs vested

Key Terms

performance-based RSUs, PSUs, vested

3 terms

performance-based RSUs financial

"award of performance-based RSUs ("PSUs") granted on July 17, 2025"

Performance-based restricted stock units (RSUs) are promises to deliver company shares to employees only if the business meets specific goals, such as revenue, profit, stock-price targets, or strategic milestones. For investors, they matter because they change future share supply and align management incentives with company results—like a salesperson whose bonus only pays out when sales targets are hit—so they can affect earnings, dilution, and confidence in leadership.

PSUs financial

"Represents common shares earned with respect to an award of PSUs"

PSUs are company shares promised to employees or executives that only become actual stock if the business hits specific performance targets over a set period. For investors, PSUs matter because they link pay to measurable outcomes — similar to a conditional bonus that converts into ownership — which can influence management decisions, dilution of shares, and signals about confidence in future results.

vested financial

"100% of the PSUs vested on July 15, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 05:52 PM Accepted by SEC EDGAR 07/17/2026 - 05:51 PM

FAQ

What insider transaction did KMTS report for Alfred J. Ford Jr.?

Alfred J. Ford Jr., Chief Commercial Officer, acquired 58,832 Common Shares of KMTS on July 15, 2026. The shares were earned from a performance-based RSU award granted July 17, 2025 that vested 100% based on specified performance goals.

How many KMTS shares does Alfred J. Ford Jr. hold after this Form 4 transaction?

After the reported transaction, Alfred J. Ford Jr. directly holds 133,471 Common Shares of KMTS. This reflects the addition of 58,832 shares earned upon vesting of performance-based RSUs, as determined by the company’s achievement of specified performance goals.

On what dates were the KMTS PSUs granted and when did they fully vest?

The performance-based RSUs for KMTS were granted on July 17, 2025 and vested 100% on July 15, 2026. Vesting and share delivery were contingent on the issuer’s achievement of specified performance goals linked to that PSU award.

Was the KMTS insider transaction by Alfred J. Ford Jr. under a Rule 10b5-1 plan?

The Form 4 for KMTS indicates the transaction was not marked as pursuant to a Rule 10b5-1 plan. The document-level 10b5-1 checkbox is unchecked, so the reported award vesting is not identified as occurring under a pre-arranged trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ford Alfred J Jr

(Last)

(First)

(Middle)

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND

WASHINGTON

98033

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	07/15/2026		A		58,832⁽¹⁾	A	$0	133,471	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.

	/s/ Traci S. Umberger as attorney-in-fact for Alfred J. Ford Jr.	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR